Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2007, p. 3405-3416, Vol. 27, No. 9
0270-7306/07/$08.00+0 doi:10.1128/MCB.00066-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Guillermina Lozano,2,3 and
Sharon Y. R. Dent1,2*
Department of Biochemistry and Molecular Biology,1 Program in Genes and Development,2 Department of Cancer Genetics, University of Texas M. D. Anderson Cancer Center, Houston, Texas 770303
Received 12 January 2007/ Returned for modification 1 February 2007/ Accepted 14 February 2007
Gcn5 was the first transcription-related histone acetyltransferase (HAT) to be identified. However, the functions of this enzyme in mammalian cells remain poorly defined. Deletion of Gcn5 in mice leads to early embryonic lethality with increased apoptosis in mesodermal lineages. Here we show that deletion of p53 allows Gcn5/ embryos to survive longer, but Gcn5/ p53/ embryos still die in midgestation. Interestingly, embryos homozygous for point mutations in the Gcn5 catalytic domain survive significantly longer than Gcn5/ or Gcn5/ p53/ mice. In contrast to Gcn5/ embryos, Gcn5hat/hat embryos do not exhibit increased apoptosis but do exhibit severe cranial neural tube closure defects and exencephaly. Together, our results indicate that Gcn5 has important, HAT-independent functions in early development and that Gcn5 acetyltransferase activity is required for cranial neural tube closure in the mouse.
Published ahead of print on 26 February 2007.
Present address: Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»